1/12
07:20 am
mdwd
MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference [Yahoo! Finance]
Medium
Report
MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/12
07:00 am
mdwd
MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference
Medium
Report
MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare Conference
12/19
07:04 pm
mdwd
MediWound Ltd. (NASDAQ:MDWD) is a favorite amongst institutional investors who own 52% [Yahoo! Finance]
Low
Report
MediWound Ltd. (NASDAQ:MDWD) is a favorite amongst institutional investors who own 52% [Yahoo! Finance]
12/10
07:00 am
mdwd
MediWound Reports New Clinical Data Demonstrating NexoBrid®’s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries
Medium
Report
MediWound Reports New Clinical Data Demonstrating NexoBrid®’s Effectiveness in Preventing Traumatic Tattoos After Abrasion and Blast Injuries
11/21
07:10 am
mdwd
MediWound (NASDAQ:MDWD) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
MediWound (NASDAQ:MDWD) had its "buy" rating reaffirmed by analysts at HC Wainwright.
11/20
10:45 am
mdwd
MediWound Ltd. (MDWD) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
MediWound Ltd. (MDWD) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/20
10:13 am
mdwd
MediWound (MDWD) Reports Q3 Loss, Misses Revenue Estimates [Yahoo! Finance]
Medium
Report
MediWound (MDWD) Reports Q3 Loss, Misses Revenue Estimates [Yahoo! Finance]
11/20
07:20 am
mdwd
MediWound: Q3 Earnings Snapshot [Yahoo! Finance]
Low
Report
MediWound: Q3 Earnings Snapshot [Yahoo! Finance]
11/20
07:00 am
mdwd
MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Low
Report
MediWound Reports Third Quarter 2025 Financial Results and Provides Corporate Update
11/13
07:22 am
mdwd
MediWound (NASDAQ:MDWD) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Low
Report
MediWound (NASDAQ:MDWD) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
11/5
07:30 am
mdwd
MediWound to Report Third Quarter 2025 Financial Results
Low
Report
MediWound to Report Third Quarter 2025 Financial Results
11/3
08:00 am
mdwd
MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid®
Low
Report
MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid®